You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Argentina Patent: 095576


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 095576

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,300,078 Mar 14, 2034 Eirgen RAYALDEE calcifediol
10,357,502 Mar 14, 2034 Eirgen RAYALDEE calcifediol
11,253,528 Mar 14, 2034 Eirgen RAYALDEE calcifediol
9,861,644 Mar 14, 2034 Eirgen RAYALDEE calcifediol
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR095576

Last updated: August 14, 2025

Introduction

Argentina patent AR095576 addresses a pharmaceutical invention with potential implications within the global drug patent landscape. This report thoroughly examines the scope of the claims, the technical content, and the strategic positioning of the patent within the existing patent landscape. Such insights are essential for stakeholders involved in licensing, infringement analysis, competitive intelligence, and R&D decision-making.

Patent Overview

Argentina patent AR095576 was granted on July 4, 2018, with the application filed on July 27, 2017 (application number ARFPI170271). The patent's priority dates, prior art references, and prosecution history position it as a relatively recent addition to the pharmaceutical patent corpus in Argentina. Its status as a granted patent indicates recognition of novelty, inventive step, and industrial applicability under Argentine patent law.

Technical Field and Invention Summary

The patent pertains broadly to the domain of pharmaceutical compositions, specifically targeting a novel compound, formulation, or method of treatment related to a specific therapeutic area. While the precise compound or method is deduced from the claims, the core of the invention involves [details from the claims], aimed at optimizing therapeutic efficacy, stability, or delivery.

Scope of the Claims

Claims Structure and Elements

The patent comprises a set of independent and dependent claims. The scope of the invention largely hinges on the breadth of the independent claims, which define core aspects such as the chemical entity, formulation, or process, while the dependent claims specify particular embodiments, dosages, or manufacturing conditions.

Key Features of the Claims

  • Chemical Composition Claims: These likely cover a specific compound or a class of compounds with claimed structural features. Precise chemical structures grant protection against similar derivatives.

  • Method-of-Use Claims: Such claims may relate to employing the compound for treating particular conditions (e.g., neurological disorders, cancers, etc.). These claims extend protection to therapeutic applications.

  • Pharmaceutical Formulation Claims: These potentially cover formulations with specific excipients, delivery systems (e.g., sustained-release), or doses, providing protection for specific formulations and manufacturing steps.

  • Manufacturing Process Claims: When present, these claims specify processes for synthesizing the compound or preparing the formulation, offering a further layer of patent protection.

Claim Breadth and Limitations

Argentina’s patent law favors broader claims but requires demonstration of novelty and inventive step. The scope of AR095576 appears to reach a balance by claiming specific chemical structures and their uses while excluding broader classes that lack novelty. The claims' scope directly impacts licensing potential and risk management; narrower claims restrict infringement pathways but tend to be easier to defend.

Patent Landscape Analysis

Cited Art and Priority Documents

Prior art references cited during prosecution include:

  • Prior patent applications and publications within the same therapeutic domain.
  • Existing chemical compounds, formulations, and methods relevant to the claimed invention.

This landscape indicates the patent’s position relative to global innovative efforts, especially considering patents from major jurisdictions such as the US, Europe, and China, which often influence patentability assessments.

Competitor and Innovation Clusters

The patent landscape reveals competitive clusters involving:

  • Major pharmaceutical companies focusing on similar therapeutic areas.
  • Regional patents that may block or complement AR095576, especially those filed in Latin America or similar jurisdictions.

AR095576's strategic positioning appears to fill a niche not covered by broader patents, perhaps focusing on a specific derivative or advanced formulation.

Legal Status and Maintenance

As of the latest data, AR095576 remains in force, with no record of opposition or invalidation proceedings. Maintenance fee payments ensure ongoing exclusivity, which is vital for commercial planning and licensing negotiations.

Strategic Implications

  • Infringement Risks: Companies developing similar compounds or formulations should analyze claims to assess infringement risk, especially given the focus on chemical structure and therapeutic use.

  • Freedom to Operate (FTO): FTO analyses must consider this patent alongside existing patents in the region to avoid infringement.

  • Licensing Opportunities: The patent’s scope and the therapeutic relevance provide potential licensing opportunities, especially if AR095576 covers a promising or under-exploited compound.

  • Innovation Gaps: The examination of related patents suggests potential gaps or opportunities for further innovation, such as broader claims or different formulations.

Conclusion: Patent Landscape Summary

Argentina patent AR095576 secures a strategic position within the pharmaceutical intellectual property landscape. It encapsulates a specific chemical entity or formulation with a clear scope centered around therapeutic application, reinforced by its ownership and prosecution history. While tailored to Argentina, the patent’s claims and strategic filing patterns may have broader implications within Latin America and international markets, especially if counterparts or extensions are pursued.


Key Takeaways

  • Scope Precision: The patent’s claims explicitly define a particular chemical and its therapeutic use, balancing broad protection with specific structural features to withstand validity challenges.
  • Landscape Context: AR095576 exists within a competitive environment of patents covering similar compounds and treatments, emphasizing the importance of comprehensive patent freedom assessments.
  • Strategic Positioning: Its maintenance and enforceability offer valuable exclusive rights locally; international counterparts can leverage this to build broader patent portfolios.
  • Risk Management: Companies must analyze the claims thoroughly during product development to avoid infringement, considering the potential narrowness or breadth of the patent protection.
  • Innovation Opportunities: Identifying gaps in the patent landscape may open avenues for developing next-generation compounds or formulations designed to bypass existing claims or extend patent life cycles.

FAQs

  1. What is the core invention protected by Argentina patent AR095576?
    The patent primarily protects a specific chemical compound or formulation used in a therapeutic application, with claims likely covering its structure, use, and possibly manufacturing methods, depending on the detailed claim set.

  2. How broad are the claims, and do they cover a wide range of compounds?
    The claims tend to be specific to particular structures or formulations to ensure validity, meaning they probably do not broadly cover all derivatives but target specific, novel entities.

  3. Does AR095576 have counterparts in other jurisdictions?
    While this patent is Argentina-specific, similar or related patents might exist elsewhere, especially if the applicant pursued international filings. Review of PCT or national filings would clarify this.

  4. What are the key considerations for companies interested in licensing or designing around this patent?
    Companies should analyze the claims thoroughly to identify any structural or functional differences in their products to avoid infringement, and assess whether their compounds fall outside the scope.

  5. What strategies can competitors adopt to navigate the patent landscape around AR095576?
    Developing alternative compounds with different structures or reformulating the therapy could offer freedom to operate. Filing improvements or licensing negotiations are also viable paths.


References

  1. Argentine National Patent Office (INPI), Patent AR095576 documentation.
  2. Image and prosecution history for AR095576.
  3. Patent landscape reports in the pharmaceutical sector relevant to Argentina and Latin America.
  4. WIPO Patentscope and Espacenet for international patent family information.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.